22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
One of the critical elements found in the 2019 Guidance is the need to use the information you obtai...
Read More >
As we move into 2020, there are signs that the M&A market may be slowing down. Global trade issues,...
Read More >
On January 13, 2020, the U.S. Department of Labor (DOL) released its long-awaited final rule regardi...
Read More >
It’s no secret that many employers have employees sign arbitration agreements with class and collec...
Read More >
The Washington Supreme Court yesterday ruled, for the first time in Washington, that obesity can be ...
Read More >
Medical device and diagnostics companies and laboratories should anticipate significant legal, regul...
Read More >